Ledger.Open graph →
SEC Form D · filed April 17, 2020

FlightPath Biosciences, Inc

Offering
$5.0M
Sold
$350K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BERKELEY, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Curtis L. Scribner · Berkeley, CAExecMatthew C. Tindall · Berkeley, CAExec · DirectorMark P. De Souza · Berkeley, CAExec · DirectorJett Mccandless · Chicago, ILExec · DirectorKevin Diestel · Chicago, ILExecJoseph Floyd · Chicago, ILExec · DirectorJayakumar C. Rajadas · Berkeley, CADirectorKatherine G. Saxton · Westlake Village, CAExec · DirectorChristopher G. Tune · Westlake Village, CAExecSteve G. De Forest · Westlake Village, CAExec · DirectorJayakumar C. Rajadas · Berkeley, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗